Secoisolariciresinol
PreliminaryMechanism of Action
Research Notes
Preclinical studies show SECO and its metabolites reduce DHT-stimulated LNCaP prostate cancer cell proliferation by 20–40% at physiologically achievable concentrations. Epidemiological data associating high urinary enterolactone excretion with reduced prostate cancer risk support a population-level chemopreventive hypothesis. Clinical interventional data specific to nettle root-derived lignans are absent; most lignan research focuses on flaxseed as a richer source. Gut microbiome composition significantly governs SECO conversion efficiency, introducing substantial inter-individual pharmacokinetic variability.
Found In 1 Herb
3D Molecular Structure
Secoisolariciresinol
Representative pattern: C₄H₂NO
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
